New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 26, 2012
05:55 EDTAMD, AMD, AMD, AMD, AMD, VAR, VAR, VAR, VAR, VAR, RDNT, RDNT, RDNT, RDNT, RDNT, PKI, PKI, PKI, PKI, PKI, NTAP, NTAP, NTAP, NTAP, NTAP, MDT, MDT, MDT, MDT, MDT, HOLX, HOLX, HOLX, HOLX, HOLX, EMC, EMC, EMC, EMC, EMC, DELL, DELL, DELL, DELL, DELL, CERN, CERN, CERN, CERN, CERN, AWRE, AWRE, AWRE, AWRE, AWRE, ATHN, ATHN, ATHN, ATHN, ATHN, T, T, T, T, T, VMW, VMW, VMW, VMW, VMWRadiological Society of North America hosts a conference
RSNA 2012 is being held in Chicago on November 25-30.
News For AMD;T;ATHN;AWRE;CERN;DELL;EMC;HOLX;MDT;NTAP;PKI;RDNT;VAR;VMW From The Last 14 Days
Check below for free stories on AMD;T;ATHN;AWRE;CERN;DELL;EMC;HOLX;MDT;NTAP;PKI;RDNT;VAR;VMW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
September 18, 2014
17:03 EDTAMDAMD, Synopsys expand IP partnership
Subscribe for More Information
12:58 EDTVMW, EMCEarnings Preview: Morgan Stanley views Oracle's Q1, Q2 estimates as 'achievable'
Subscribe for More Information
12:23 EDTTAT&T ex-partners look to FCC to hinder DirecTV offer, Reuters says
Subscribe for More Information
12:18 EDTMDTNY AG announces national settlement with Medtronic for Medicaid violations
Attorney General Eric T. Schneiderman announced that 46 states and the District of Columbia have reach a settlement agreement with Minnesota-based company Medtronic to resolve claims under the False Claims Act that Medtronic improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease. New York led a national team composed of members from Oregon, Texas and California to negotiate the settlement. The federal government settled its matter in May of this year...The agreement requires Medtronic to pay the settling states $362,362, which will go to those states’ Medicaid programs. The matter was brought by a whistleblower, Adolfo Schroeder, and was filed in U.S. District Court for the Eastern District of California. The Attorney General would like to thank Mr. Schroeder for bringing this matter to the government’s attention. Under the terms of the agreement, the New York Medicaid Program will receive $67,369.31. Reference Link
09:34 EDTTAT&T extends NetBond security services to IBM SoftLayer platform
Subscribe for More Information
05:56 EDTAMDStocks with implied volatility top IV index mean; AMD BBRY
Subscribe for More Information
September 17, 2014
15:06 EDTTAT&T met with Mexican telecommunications regulators, Bloomberg says
Subscribe for More Information
13:34 EDTTAT&T could need significant debt to pursue America Movil assets, WSJ says
Subscribe for More Information
11:39 EDTTVerizon says tower sales options more favorable in current market
Subscribe for More Information
09:08 EDTMDTMedtronic launches new Balloon Kyphoplasty Platform
Subscribe for More Information
07:43 EDTMDTBofA/Merrill to hold a conference
Subscribe for More Information
06:09 EDTMDTIntegra LifeSciences to acquire Medtronic instrumentation lines for $60M
Integra LifeSciences (IART) and Medtronic (MDT) announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines for approximately $60M in cash. Integra expects the transaction to close in Q4. Integra will acquire a portfolio of approximately 4,000 MicroFrance and Xomed manual ENT and laparoscopic surgical instruments, as well as the St. Aubin le Monial, France manufacturing facility. Sales from the products being acquired totaled approximately $30M, two-thirds of which were generated outside the U.S. Integra expects to record approximately $27M-$30M in revenue and approximately 10c of adjusted EPS in calendar 2015 from this acquisition. The earnings accretion should rise after the first year once certain sales transitions are complete. The company expects the acquisition to contribute less than $5M in revenue and be neutral to earnings in Q4. The transition and integration is expected to be completed by 2H15.
05:55 EDTAMDStocks with implied volatility top IV index mean; AMD ADBE
Subscribe for More Information
September 16, 2014
17:41 EDTTAT&T indicates interest in Mexico market, WSJ says
AT&T's (T) Chief Strategy Officer, John Stankey, speaking at an investor conference, said that Mexico, a fast growing market, is of interest to AT&T and the company has the balance sheet to do a deal if an opportunity arises, says the Wall Street Journal. América Móvil (AMX,AMOV) recently said it will sell off assets in Mexico to comply with regulatory issues there, added the Wall Street Journal. Reference Link
17:32 EDTTAT&T signs agreement with Shell to upgrade unified communications platform
Subscribe for More Information
11:51 EDTMDTOECD looks to close tax loopholes with new proposals
Subscribe for More Information
09:05 EDTEMCEMC selects ADP for human capital management
Subscribe for More Information
08:07 EDTMDTMedtronic drug-coated baloon shows strong clinical, economic benefit
Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics, or TCT, conference, the latest clinical and economic data on the IN.PACT Admiral drug-coated balloon, or DCB, from Medtronic augments an already robust body of evidence that continues to drive a reconsideration of the standard of care for peripheral artery disease, or PAD, in leg arteries above the knee. The IN.PACT Admiral DCB remains an investigational medical device in the United States. No drug-coated balloon has yet received approval from the FDA. The new data come from the real-world IN.PACT Global study, the largest and most rigorous post-market evaluation of its kind for any peripheral artery intervention, and from an ongoing economic outcomes analysis of the U.S. phase of the landmark IN.PACT SFA trial. Together, the results show that the IN.PACT Admiral DCB is not only clinically superior, but also cost-effective for the treatment of atherosclerotic lesions in the superficial femoral artery, or SFA, or proximal popliteal artery, or PPA, at 12 months compared to standard percutaneous transluminal angioplasty, or PTA.
07:31 EDTMDTEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.
07:27 EDTTBofA/Merrill to hold a conference
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use